Dr. Nicolas André is Professor in Pediatric Oncology in the Department of Hematology & Pediatric Oncology in the “Timone Infant Hospital”, AP-HM and head of the SMARTC CRCM- (Centre de Recherche en Cancérologie de Marseille), AMU, France.
He gained his medical degree in 2002 and a doctoral degree in 2003. He is the former president of the “Société Francophone de Recherche en Pédiatrie”. Currently, his research interests and topics include paediatric brain tumors, pediatric rare tumors and pharmacology (new anticancer agents, metronomic chemotherapy, microtubule-targeting agents). His has developed over the years an international expertise in metronomic chemotherapy.
The use of metronomic chemotherapy in "his" own patients has convinced him that this tool could be valuable for children in developing countries. He initiated with Dr Fousseiny Traore a pilot study in Bamako (Mali) that further convinced him of the unveiled potential of metronomic chemotherapy.
He then imaginated Metronomics-Global-Health–Initiative as the structure that could promote the development of metronomics with the highest standards and pave the way for new global strategies to fight cancer in developing countries.
He will be the leader of Metronomics-Global-Health–Initiative connecting & coordinating a community of institutions and people who will embark in this forward-looking project as inventors, ambassadors, sponsors and supporters.
He is the author of over 100 peer reviewed publications and book chapters and has given lectures on metronomics worldwide.